EU-UKRAINE COOPERATION COUNCIL FIFTEENTH MEETING?
Vice President Tajani and Commissioner Poto?nik have swiftly followed up on their undertaking given during their Hearings in the European Parliament by together visiting the European Chemicals Agency, ECHA, in Helsinki on 25 March. They are taking action to make progress towards the registration of chemicals and the management of substances of very high concern. Of particular importance is the smooth implementation of the registration of high-volume chemicals by the REACH deadline of 30 November 2010 by implementing solutions to practical problems to support industrys work, in particular SMEs. Both Commissioners also announced their common approach on the identification and management of substances of very high concern. They also welcomed progress on the translation of the guidelines for the implementation of REACH. Both commissioners underlined their commitment to the success of REACH, the European Chemicals Regulation.
A study carried out by the team of Immune Endocrinology of CNR from Naples, published on the Journal of Clinical Investigation, has underlined the key role played by leptine - a hormone regulating body weight - in the aetiology of serious autoimmune diseases such as experimental multiple sclerosis (experimental allergic encephalitis EAE) and autoimmune diabetes.